Glenmede Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $525K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $614K | Hold |
|
|||||
|
2023
Q1 | $614K | Buy |
|
|||||
|
2022
Q4 | $564K | Buy |
|
|||||
|
2022
Q3 | $532K | Sell |
|
|||||
|
2022
Q2 | $456K | Sell |
|
|||||
|
2022
Q1 | $9.38M | Sell |
|
|||||
|
2021
Q4 | $16.2M | Sell |
|
|||||
|
2021
Q3 | $15M | Sell |
|
|||||
|
2021
Q2 | $17.5M | Sell |
|
|||||
|
2021
Q1 | $14.9M | Buy |
|
|||||
|
2020
Q4 | $12.4M | Sell |
|
|||||
|
2020
Q3 | $11.1M | Sell |
|
|||||
|
2020
Q2 | $14.5M | Sell |
|
|||||
|
2020
Q1 | $18.5M | Hold |
|
|||||
|
2019
Q4 | $18.5M | Sell |
|
|||||
|
2019
Q3 | $24.3K | Sell |
|
|||||
|
2019
Q2 | $34.7K | Sell |
|
|||||
|
2019
Q1 | $45K | Buy |
|
|||||
|
2018
Q4 | $40K | Buy |
|
|||||
|
2018
Q3 | $50M | Buy |
|
|||||
|
2018
Q2 | $39.1M | Buy |
|
|||||
|
2018
Q1 | $25.2M | Hold |
|
|||||
|
2017
Q4 | $25.2M | Sell |
|
|||||
|
2017
Q3 | $28.8M | Sell |
|
|||||
|
2017
Q2 | $33.5M | Hold |
|
|||||
|
2017
Q1 | $33.5M | Sell |
|
|||||
|
2016
Q4 | $29.2M | Sell |
|
|||||
|
2016
Q3 | $38.6M | Sell |
|
|||||
|
2016
Q2 | $36.2M | Sell |
|
|||||
|
2016
Q1 | $28.1M | Sell |
|
|||||
|
2015
Q4 | $25.5M | Buy |
|
|||||
|
2015
Q3 | $16.7M | Buy |
|
|||||
|
2015
Q2 | $481K | Buy |
|